Intravitreal Injections by Nurses or Physicians: a Randomized Controlled Trial Comparing Efficacy, Patient Satisfaction and Health Economy
Overview
- Phase
- Not Applicable
- Intervention
- Anti-VEGF agents
- Conditions
- Eye Diseases
- Sponsor
- St. Olavs Hospital
- Enrollment
- 328
- Locations
- 1
- Primary Endpoint
- change in visual acuity
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Anti-VEGF agents are given for a variety of previously untreatable eye diseases. The last years indications for their use and consequently the number of patients needing treatment, have been increasing. Most patients require multiple injections. This has resulted in many eye departments administering thousands of injections per year, also at St Olavs University Hospital Trondheim. To cope with this increase in workload, it would be helpful if injections would be given not only by the physicians but also by the nurses. This study's objective is to compare efficiency, patient satisfaction and cost per patient of injections given by nurses and physicians.
Investigators
Eligibility Criteria
Inclusion Criteria
- •referred to the eye clinic for treatment of age related macular degeneration, diabetes retinopathy or retinal vein occlusion with anti-vascular endothelium growth factor
- •Ability to provide written informed consent
- •ability to comply with study assessments for the full duration of the study
Exclusion Criteria
- Not provided
Arms & Interventions
physician
intravitreal injections with anti-VEGF agents given by a physician
Intervention: Anti-VEGF agents
nurse
intravitreal injections with anti-VEGF agents given by a nurse
Intervention: intravitreal injections given by a nurse
nurse
intravitreal injections with anti-VEGF agents given by a nurse
Intervention: Intravitreal injections
nurse
intravitreal injections with anti-VEGF agents given by a nurse
Intervention: Anti-VEGF agents
physician
intravitreal injections with anti-VEGF agents given by a physician
Intervention: intravitreal injections given by a physician
physician
intravitreal injections with anti-VEGF agents given by a physician
Intervention: Intravitreal injections
Outcomes
Primary Outcomes
change in visual acuity
Time Frame: 1 year
Mean change in visual acuity from baseline to 12 months, tested on ETDRS letter chart
Secondary Outcomes
- incidence of ocular adverse events(from baseline to 12 months)
- patient satisfaction(12 months)